Betta Pharmaceuticals Market Cap

Betta Pharmaceuticals has a market cap or net worth of 18.76 billion as of March 18, 2026. Its market cap has decreased by -9.31% in one year.

Market Cap

18.76B

Enterprise Value

20.80B

Revenue

3.26B

Ranking

n/a

PE Ratio

61.88

Stock Price

43.70

Market Cap Chart

Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 18.76B, an increase of 84.88%. That is a compound annual growth rate of 6.78%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2026	18.76B	-4.52%
Dec 31, 2025	19.64B	-12.96%
Dec 31, 2024	22.57B	4.62%
Dec 29, 2023	21.57B	5.11%
Dec 30, 2022	20.53B	-38.09%
Dec 31, 2021	33.15B	-25.26%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 7, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Apeloa Pharmaceutical Co.,Ltd	20.84B
Joincare Pharmaceutical Group Industry	20.56B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	20.41B
Walvax Biotechnology	19.64B
Wedge Industrial	18.91B
China Resources Double-Crane Pharmaceutical	18.81B
Fujian Cosunter Pharmaceutical	18.32B
Shandong Buchang Pharmaceuticals	17.92B

Market Cap Rankings